News Focus
News Focus
Followers 13
Posts 436
Boards Moderated 0
Alias Born 07/28/2019

Re: Whalatane post# 294349

Tuesday, 09/01/2020 5:04:15 PM

Tuesday, September 01, 2020 5:04:15 PM

Post# of 447730
Thanks Kiwi. The value of Amarin's patent portfolio will change drastically if they loss the appeal (even more than 3/30) in both US and OUS. So I am not convinced at all that they can rely on patents for OUS but not in US, maybe until they're being challenged.

I am with you on JELIS and Mochida. I maybe misleading you but I remember someone in O3 business once told me that Amarin licensed it from Mochida. But I never researched this myself.But some on this board said there is some difference between Epadel and Vascepa. It's a complete mystery to me too.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News